Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 6-K, filed Sep 8, 2026
- Filings on record
- 206 filings
- On EDGAR
- CIK 1889109
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 59
- 6-K Report a foreign issuer made public elsewhere Sep 8, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 13, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 11, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 15, 2026
- 6-K Report a foreign issuer made public elsewhere May 20, 2026
- 6-K Report a foreign issuer made public elsewhere Apr 21, 2026
- 6-K Report a foreign issuer made public elsewhere Mar 31, 2026
- 20-F Annual report, foreign issuer Mar 31, 2026
Prospectuses and Registrations 8 of 19
- S-8 Registration statement for an employee plan Jan 30, 2026
- 424B5 Prospectus supplement for an offering Dec 2, 2025
- 424B5 Prospectus supplement for an offering Dec 1, 2025
- 424B5 Prospectus supplement for an offering Aug 8, 2025
- S-8 Registration statement for an employee plan Mar 21, 2025
- 424B5 Prospectus supplement for an offering Feb 7, 2025
- S-8 Registration statement for an employee plan Oct 1, 2024
- 424B5 Prospectus supplement for an offering Apr 29, 2024
Ownership 8 of 93
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- 144 Notice of a proposed sale of restricted stock Aug 12, 2026
- 144 Notice of a proposed sale of restricted stock Aug 12, 2026
- 4 Insider reported a trade Jun 22, 2026
- 144 Notice of a proposed sale of restricted stock Jun 18, 2026
- 4 Insider reported a trade Jun 17, 2026
- 144 Notice of a proposed sale of restricted stock Jun 16, 2026
Other 8 of 35
- F-3ASR Oct 22, 2025
- 424B7 Jan 27, 2025
- F-3ASR Jan 27, 2025
- EFFECT Notice that a registration became effective May 30, 2023
- CORRESP Reply to SEC staff May 25, 2023
- UPLOAD Comment letter from SEC staff May 25, 2023
- EFFECT Notice that a registration became effective May 9, 2023
- CORRESP Reply to SEC staff May 5, 2023
Everything here comes from Belite Bio, Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.